BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17644205)

  • 1. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration.
    Boonyo W; Junginger HE; Waranuch N; Polnok A; Pitaksuteepong T
    J Control Release; 2007 Aug; 121(3):168-75. PubMed ID: 17644205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
    Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
    Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.
    Hagenaars N; Verheul RJ; Mooren I; de Jong PH; Mastrobattista E; Glansbeek HL; Heldens JG; van den Bosch H; Hennink WE; Jiskoot W
    J Control Release; 2009 Dec; 140(2):126-33. PubMed ID: 19712713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
    Bal SM; Slütter B; Verheul R; Bouwstra JA; Jiskoot W
    Eur J Pharm Sci; 2012 Mar; 45(4):475-81. PubMed ID: 22009113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
    Slütter B; Soema PC; Ding Z; Verheul R; Hennink W; Jiskoot W
    J Control Release; 2010 Apr; 143(2):207-14. PubMed ID: 20074597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
    Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization.
    Liu Q; Zhang C; Zheng X; Shao X; Zhang X; Zhang Q; Jiang X
    Vaccine; 2014 May; 32(22):2582-90. PubMed ID: 24681230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.
    Bal SM; Slütter B; Jiskoot W; Bouwstra JA
    Vaccine; 2011 May; 29(23):4025-32. PubMed ID: 21443959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
    Slütter B; Jiskoot W
    J Control Release; 2010 Nov; 148(1):117-121. PubMed ID: 20600405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
    Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.
    Bal SM; Slütter B; van Riet E; Kruithof AC; Ding Z; Kersten GF; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Mar; 142(3):374-83. PubMed ID: 19932723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system.
    Hori M; Onishi H; Machida Y
    Int J Pharm; 2005 Jun; 297(1-2):223-34. PubMed ID: 15885938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
    Verheul RJ; Slütter B; Bal SM; Bouwstra JA; Jiskoot W; Hennink WE
    J Control Release; 2011 Nov; 156(1):46-52. PubMed ID: 21784113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine.
    Hagenaars N; Mania M; de Jong P; Que I; Nieuwland R; Slütter B; Glansbeek H; Heldens J; van den Bosch H; Löwik C; Kaijzel E; Mastrobattista E; Jiskoot W
    J Control Release; 2010 May; 144(1):17-24. PubMed ID: 20100528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
    Tafaghodi M; Saluja V; Kersten GF; Kraan H; Slütter B; Amorij JP; Jiskoot W
    Vaccine; 2012 Aug; 30(36):5341-8. PubMed ID: 22749834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.
    Dabaghian M; Latifi AM; Tebianian M; NajmiNejad H; Ebrahimi SM
    Vaccine; 2018 May; 36(20):2886-2895. PubMed ID: 29627234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant effect of ethanol extract of Semen Cuscutae on the immune responses to ovalbumin in mice.
    Pan HJ; Sun HX; Pan YJ
    J Ethnopharmacol; 2005 May; 99(1):99-103. PubMed ID: 15848026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effectiveness and safety of chitosan derivatives as adjuvants for intranasal vaccines.
    Kobayashi T; Fukushima K; Sannan T; Saito N; Takiguchi Y; Sato Y; Hasegawa H; Ishikawa K
    Viral Immunol; 2013 Apr; 26(2):133-42. PubMed ID: 23509985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.